News - The Strengthening of Ebiox

November 16 2011

New Trionic D Wipe Dispensing System

Ebiox has launched its new dispensing system utilising the well proven and accepted Trionic D Wipes for cleaning and disinfection. Ideally suited for smaller clinical areas and ambulances with a wall mounted perspex holder and a flat pack of 50 medium size wipes which can be replaced when empty.

Natural Esense

Natural Esense is their first hand hygiene product based on sustainable natural ingredients, Natural Esense™. Extracted from the pith of Seville Oranges (Citrus Aurantium), Natural Esense is a proprietary formula, and is classed under the Bioflavonoid Complex classification. Tested extensively to European regulatory standards and other supporting studies, Natural Esense provides effective bacterial, virucidal, fungicidal and sporicidal protection.

There is a growing interest in non alcohol based products especially within hand hygiene with Infection Prevention and Control teams looking for answers to help drive forward the levels of compliance to their hand hygiene protocols.

Natural Esense will be made available in a variety of dispensing systems.

Trionic A2Z Dry Mist System

Following extensive redesign and upgrade programme led by Amazon Bio-Guard Ltd, Ebiox has launched the new system for total room or vehicle disinfection.

There is a growing demand for total room or vehicle disinfection and there are a number of competitors already offering such devices into our market sector, however there can be a number of issues with the current offering, process time, complex protocols, complex systems, cost, damage to materials in the room and surface wetting.

The Trionic A2Z Area Disinfection System has a number of features which provides answers to a number of these issues:

  Simple and easy to use system
  No complex protocols
  Shorter process times
  No surface wetting
  Very Cost effective
  Use as an ongoing preventative measure

We believe this is an excellent addition to our product portfolio, one which offers many opportunities and the potential for pull through of other products such as Trionic wipes. Our aim as Ebiox is to offer a comprehensive range of solutions for Infection Prevention and Control.

Financial

The Directors of Ebiox Limited are pleased to announce that the company has completed a rights issue of £700,000 to strengthen its balance sheet and provide further working capital funding to grow the business.

The Directors were informed in July 2011 that Healthcare Enterprise Group plc had been put into liquidation, but would note that Healthcare Enterprise Group plc ceased to own Ebiox Limited in July 2009 and their current shareholding only represents 7% of the Company’s ordinary share capital.